Clinical trial Recruiting at 1 site Observational Ages 0 to 20

Understanding how drugs work in children with leukemia

Official title: Pharmacokinetics of Drugs Administered to Children Per Standard of Care

Run by Duke University · NCT03481881 · Data updated 2026-11-12

This study looks at how well certain leukemia medications work in children under 21 to better understand their safety and effectiveness.

Quick facts

Study typeObservational
Ages0 Years to 20 Years
SexAll
Enrollment200 (estimated)
SponsorDuke University
Academic / other
Locations1 site (Durham, North Carolina)
StatusRecruiting
StartedAugust 14, 2013
Main results expectedAugust 14, 2033
Study endsAugust 14, 2033
Registry record updatedJanuary 7, 2026
Trial IDNCT03481881 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children under 21 years of age who are receiving specific drugs for pediatric ALL as part of their standard treatment.

Probably not a fit

Patients who are not receiving the drugs of interest or those who cannot provide consent or assent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to characterize the pharmacokinetics (PK) of drugs administered to children under 21 years of age who are receiving treatment for pediatric acute lymphoblastic leukemia (ALL). The study will involve monitoring the standard of care drugs prescribed by the treating caregivers to gather data on how these medications are processed in the bodies of young patients. By focusing on understudied drugs, the research seeks to fill gaps in knowledge regarding their effectiveness and safety in this specific population.

Why it matters

Potential benefit: If successful, this study could lead to improved drug dosing and treatment strategies for children with leukemia, enhancing their overall care.

How similar studies have gone: While pharmacokinetics studies in pediatric populations are common, this specific focus on understudied drugs in pediatric ALL is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children (\< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver

Exclusion Criteria:

* Failure to obtain consent/assent (as indicated)

Where it's running

  • Duke University
    Durham, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.